Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.2 USD | -0.01% | +3.31% | +36.39% |
Sales 2024 * | 266M 20.95B | Sales 2025 * | 428M 33.65B | Capitalization | 4.83B 380B |
---|---|---|---|---|---|
Net income 2024 * | 62M 4.88B | Net income 2025 * | 160M 12.58B | EV / Sales 2024 * | 15.9 x |
Net cash position 2024 * | 594M 46.71B | Net cash position 2025 * | 799M 62.82B | EV / Sales 2025 * | 9.43 x |
P/E ratio 2024 * |
74.9
x | P/E ratio 2025 * |
30.7
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.24% |
Latest transcript on Krystal Biotech, Inc.
1 day | -0.29% | ||
1 week | +3.31% | ||
Current month | +10.50% | ||
1 month | +4.42% | ||
3 months | +51.98% | ||
6 months | +64.48% | ||
Current year | +36.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 14/04/16 | |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 31/10/16 |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Dino Rossi
BRD | Director/Board Member | 69 | 31/05/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
23/05/24 | 169.2 | -0.03% | 27 804 |
22/05/24 | 169.2 | +1.45% | 338,846 |
21/05/24 | 166.8 | +1.45% | 179,150 |
20/05/24 | 164.4 | +0.21% | 185,232 |
17/05/24 | 164.1 | +0.20% | 180,034 |
Delayed Quote Nasdaq, May 23, 2024 at 03:16 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.39% | 4.83B | |
+10.57% | 115B | |
+12.40% | 106B | |
-5.38% | 24.69B | |
-1.22% | 21.97B | |
-4.87% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.95% | 14.03B | |
+33.62% | 12.13B |
- Stock Market
- Equities
- KRYS Stock